¡¾²Î¿¼ÎÄÏס¿
  ¡¡¡¡1 Bhavsar AR. Diabetic retinopathy. The diabetes eye exam initiative. Minn Med 2002;85(6):46ª²47

¡¡¡¡2 Kaushik S, Anoop M, Atul K, Ravendra M, Pandey. Simvostatin retard progression of retinopathy in diabetic patients with hypercholesterolemia. Diabetic Research and Clinical Practice 2000;56:1ª²11

¡¡¡¡3 Ministry of Health Malaysia. Diabetic Retinopathy. Diabetes Blindness Unit.1997

¡¡¡¡4 Klein R, Sharrett AR, Klein BE, Moss SE, Folsom AR, Wong TY, Brancati FL, Hubbard LD, Couper D; ARIC Group. The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study. Ophthalmology 2002;109(7):1225

¡¡¡¡5 Freyberger H, Schifferdecker E, Schatz H. Regression of hard exudates in diabetic background retinopathy in therapy with etofibrate antilipemic agent. Med Klin (Munich) 1994;89(11):594ª²597

¡¡¡¡6 Guerci B, Meyer L, Sommer S, George JL, Ziegler O, Drouin P, Angio ª²Duprez K. Severity of diabetic retinopathy is linked to lipoprotein (a) in type 1 diabetes. Diabetes Metab 1999;25(5):412ª²418

¡¡¡¡7 Kim CH, Park HJ, Park JY, Hong SK, Yoon YH, Lee KU. High serum lipoprotein (a) levels in Korean type 2 diabetic patients with proliferative diabetic retinopathy. Diabetes Care 1998;21(12):2149ª²2151

¡¡¡¡8 Colucciello M. Diabetic retinopathy Control of systemic factors preserves vision. Postgrad Med 2004;116 (1):57ª²64

¡¡¡¡9 Charlis P, Wilkinson. Classification of diabetic retinopathy: a proposed International Clinical Disease Severity Grading Scale for Diabetic Retinopathy and Diabetic Macular Edema. http://www.medscape.com/viewprogram/2600_pnt

¡¡¡¡10 Shrestha S, Malla OK, Karki DB, Byanju RN. Retinopathy in a diabetic population. Kathmandu Univ Med J (KUMJ) 2007;5(2):204ª²209

¡¡¡¡11 Sinav S, Onelge MA, Onelge S, Sinav B.Plasma lipids and lipoproteins in retinopathy of type I (insulinª²dependent) diabetic patients. Ann Ophthalmol 1993;25(2):64ª²66

¡¡¡¡12 Klein R, Sharrett AR, Klein BE, Moss SE, Folsom AR, Wong TY, Brancati FL, Hubbard LD, Couper D; ARIC Group. The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study. Ophthalmology 2002;109(7):1225ª²1234

¡¡¡¡13 Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiological Study of Diabetic Retinopathy. IX. Fourª²year incidence and progression of diabetic retinopathy when age of diagnosis is less than 30 years. Arch Ophthalmol 1989;107(2):237ª²243

¡¡¡¡14 van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD, Polak BC. Blood pressure, lipids, and obesity are associated with retinopathy: the Hoorn study. Diabetes Care 2002;25(8):1320ª²1325

¡¡¡¡15 van Hecke MV, Dekker JM, Nijpels G, Moll AC, Heine RJ, Bouter LM, Polak BC, Stehouwer CD. Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study. Diabetologia 2005;48(7): 1300ª²1306

¡¡¡¡16 Timothy J, Alicia J, Deyi Z, Daniel T, Daniel M, Timothy G, Richard L and The DCCT/EDIC Research Group. Diabetic Retinopathy and Serum Lipoprotein Subclasses in DCCT/EDIC Chohort. Invistigative Ophthalmology & Visual Science 2004;45(3):910ª²918

¡¡¡¡17 Dimitriadis E, Griffin M, Owens D, Johnson A, Collins P, Tomkin GH. Oxidation of lowª²density lipoprotein in NIDDM: its relationship to fatty acid composition. Diabetologia 1995;38(11):1300ª²1306

¡¡¡¡18 Nouroozª²Zadeh J, Rahimi A, Tajaddiniª²Sarmadi J, Tritschler H, Rosen P, Halliwell B, Betteridge DJ. Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 1997;40(6):647ª²653

¡¡¡¡19 King RC, Dobree JH, Kok D, Foulds WS, Dangerfield WG. Exudative diabetic retinopathy:spontaneous changes and effects of a corn oil diet. Br J Ophthalmol 1963;47:666ª²672

ÉÏÒ»Ò³  [1] [2] [3]